| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |